SCHEMBL7968570

SCHEMBL7968570

O=C(O)Cc1ccccc1C1CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.53
TDP1 Q9NUW8 1/20 0.47
PTGDR2 Q9Y5Y4 2/20 0.45
CXCL8 P10145 5/20 0.45
ASPH Q12797 1/20 0.44
KDM8 Q8N371 1/20 0.44
PTGS2 P35354 2/20 0.42
AKR1B10 O60218 1/20 0.42
UGT1A9 O60656 1/20 0.42
TRPA1 O75762 1/20 0.42
ABCB11 O95342 1/20 0.42
MT-CO2 P00403 1/20 0.42
TTR P02766 1/20 0.42
ALB P02768 1/20 0.42
UGT1A6 P19224 1/20 0.42
UGT1A1 P22309 1/20 0.42
PTGS1 P23219 1/20 0.42
CXCR1 P25024 1/20 0.42
ADRA1A P35348 1/20 0.42
AGTR2 P50052 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3633503 0.93 PTGDR2 (0.54) AKR1B1TDP1PTGDR2CXCL8ASPH
SCHEMBL2550680 0.91 PTGDR2 (0.56) AKR1B1TDP1PTGDR2CXCL8PTGS2
Hydrochloric Acid SCHEMBL11528572 0.90 PTGDR2 (0.55) AKR1B1TDP1PTGDR2CXCL8PTGS2
SCHEMBL21767593 0.88 AKR1B1 (0.46) AKR1B1TDP1PTGDR2CXCL8ASPH
SCHEMBL31071979 0.88 AKR1B1 (0.46) AKR1B1TDP1PTGDR2CXCL8ASPH
SCHEMBL12281735 0.88 SLC6A2 (0.57) AKR1B1SLC6A2SLC6A4SLC6A3
SCHEMBL1156415 0.86 SLC6A2 (0.43) AKR1B1PTGDR2ASPHKDM8SLC6A2
SCHEMBL11359967 0.83 SLC6A2 (0.41) AKR1B1PTGDR2ASPHKDM8SLC6A2
SCHEMBL28401893 0.81 AKR1B1 (0.46) AKR1B1TDP1CXCL8PTGS2AKR1B10
SCHEMBL17080017 0.79 KDM4E (0.46) PTGDR2ASPHKDM8SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3116877-A1 CHEMICAL COMPOUNDS ACTING AS PERK INHIBITORS Glaxosmithkline Intellectual Property (No. 2) Limited (GB) 2017-01-18 EP disclosed
CN-103086859-B 2,4-dihydroxyl-5,6-replaces-1-halogeno-benzene derivative, its synthetic method and application thereof TSINGHUA UNIVERSITY (CN) 2015-11-11 CN disclosed
WO-2015136463-A1 CHEMICAL COMPOUNDS ACTING AS PERK INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-09-17 WO disclosed
WO-2015136463-A1 CHEMICAL COMPOUNDS ACTING AS PERK INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-09-17 WO disclosed
CN-103086859-A 2,4-dihydroxy-5,6-substituted-1-halogenobenzene derivative, synthesis method and application thereof UNIV TSINGHUA 2013-05-08 CN disclosed
US-6274583-B1 Alpha 1a adrenergic receptor antagonists MERCK & CO., INC. 2001-08-14 US disclosed
US-5977115-A Alpha 1a adrenergic receptor antagonists MERCK & CO., INC. (US) 1999-11-02 US disclosed
EP-0833637-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST MERCK & CO INC (US) 1998-07-08 EP disclosed
EP-0833637-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST Merck & Co., Inc. (US) 1998-04-08 EP disclosed
WO-1996040136-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST MERCK & CO., INC. (US) 1996-12-19 WO disclosed
EP-0059685-A1 Alpha-isopropyl or alpha-cyclopropylphenyl acetates, process for their preparation and their use in pest control CIBA-GEIGY AG (CH) 1982-09-08 EP disclosed
US-4294762-A ESTERIFICATION, DEPHOSPHORIZATION BAYER AKTIENGESELLSCHAFT (DE) 1981-10-13 US disclosed
EP-0020988-A2 Process for preparing alpha-cyano-benzyl esters; intermediates therefor and their preparation BAYER AG (DE) 1981-01-07 EP disclosed